 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Brain Metastasis
| Cereport and carboplatin |
Blood-brain barrier permealization |
Alkermes |
II |
| CotaraÔ |
Radiolabled monoclonal antibody |
Peregrine Pharmaceuticals |
III |
| Edotecarin |
Topoisomerase I inhibitors |
Pfizer |
III |
| RSR13 (efaproxiral) |
Allosteric hemoglobin sensitizer |
Allos Therapeutics |
III |
| Thalomid (thalidomide) |
Immunomodulator |
Celgene |
III |
| Xcytrin (motexafin) |
Texaphyrins radiosensitizer |
Pharmacyclics |
III |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
